Cargando…
Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review
Background: One of the five strategic directions in the World Health Organization global health sector strategy on viral hepatitis 2016–2021 is to generate strong strategic information for focused action to understand the viral hepatitis epidemic and focus the response. Knowledge of national prevale...
Autores principales: | Sperle, Ida, Steffen, Gyde, Leendertz, Siv Aina, Sarma, Navina, Beermann, Sandra, Thamm, Roma, Simeonova, Yanita, Cornberg, Markus, Wedemeyer, Heiner, Bremer, Viviane, Zimmermann, Ruth, Dudareva, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493659/ https://www.ncbi.nlm.nih.gov/pubmed/33014960 http://dx.doi.org/10.3389/fpubh.2020.00424 |
Ejemplares similares
-
The epidemiology of Hepatitis B, C and D in Germany: A scoping review
por: Steffen, Gyde, et al.
Publicado: (2020) -
Hepatitis B vaccination coverage in Germany: systematic review
por: Steffen, Gyde, et al.
Publicado: (2021) -
Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens
por: Zimmermann, Ruth, et al.
Publicado: (2020) -
Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019
por: Maisa, Anna, et al.
Publicado: (2021) -
Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019
por: Maisa, Anna, et al.
Publicado: (2022)